Robust L-type calcium current expression following heterozygous knockout of the Cav1.2 gene in adult mouse heart

Journal of Physiology

Volumn 589, Issue 13, 2011, Pages 3275-3288

  Rosati, Barbara ^a,c   Yan, Qinghong ^b   Lee, Mi Sun ^c   Liou, Shian Ren ^c   Ingalls, Brian ^d   Foell, Jason ^e   Kamp, Timothy J ^e   Mckinnon, David ^b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF WATERLOO   (Canada)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIS OIL; CALCIUM CHANNEL CAV1.2; CALCIUM CHANNEL L TYPE; CRE RECOMBINASE; ION CHANNEL; MESSENGER RNA; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DNA MODIFICATION; GENE DELETION; GENE EXPRESSION; HEART CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE CONTRACTILE FORCE; HETEROZYGOSITY; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STEADY STATE; SURVIVAL TIME; WESTERN BLOTTING;

AGE FACTORS; ALLELES; ANIMALS; CALCIUM CHANNELS, L-TYPE; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; HETEROZYGOTE DETECTION; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; MYOCYTES, CARDIAC;

EID: 79959754361     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.210237     Document Type: Article

References (51)

1. 2+ release by the γ1 subunit of the dihydropyridine receptor of skeletal muscle. BMC Physiol 1, 8.
2. Bean BP & Rios E (1989). Nonlinear charge movement in mammalian cardiac ventricular cells. Components from Na and Ca channel gating. J Gen Physiol 94, 65-93.
3. Beuckelmann DJ, Nabauer M & Erdmann E (1991). Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol 23, 929-937.
4. Bodi I, Mikala G, Koch SE, Akhter SA & Schwartz A (2005). The L-type calcium channel in the heart: the beat goes on. J Clin Invest 115, 3306-3317.
5. Brew HM, Gittelman JX, Silverstein RS, Hanks TD, Demas VP, Robinson LC, Robbins CA, McKee-Johnson J, Chiu SY, Messing A & Tempel BL (2007). Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons. J Neurophysiol 98, 1501-1525.
6. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD & Gwathmey JK (1992). Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol Heart Circ Physiol 263, H1576-H1586.
7. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA & Wang Q (1998). Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392, 293-296.
8. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ Res 91, 517-524.
9. Delisle BP, Anson BD, Rajamani S & January CT (2004). Biology of cardiac arrhythmias: ion channel protein trafficking. Circ Res 94, 1418-1428.
10. Deutsch C (2003). The birth of a channel. Neuron 40, 265-276.
11. + channel gene KCNJ2 constitute a rare cause of long QT syndrome. J Mol Cell Cardiol 37, 593-602.
12. Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S & Demolombe S (2007). Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol 582, 675-693.
13. V1.2 encodes a transcription factor. Cell 127, 591-606.
14. Hadley RW & Lederer WJ (1991). Properties of L-type calcium channel gating current in isolated guinea pig ventricular myocytes. J Gen Physiol 98, 265-285.
15. 2+ channels in canine tachycardia-induced heart failure. Cardiovasc Res 49, 298-307.
16. Kobayashi T, Yamada Y, Fukao M, Tsutsuura M & Tohse N (2007). Regulation of Cav1.2 current: interaction with intracellular molecules. J Pharmacol Sci 103, 347-353.
17. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E & Kass DA (2009). Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res 105, 12-15.
18. to and confers susceptibility to ventricular tachycardia. Cell 107, 801-813.
19. Larionov A, Krause A & Miller W (2005). A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 6, 62.
20. Liu Z, Golowasch J, Marder E & Abbott LF (1998). A model neuron with activity-dependent conductances regulated by multiple calcium sensors. J Neurosci 18, 2309-2320.
21. ++ channel density in rat tissue. J Pharmacol Exp Ther 263, 540-545.
22. 2+ channel density in rat cardiac tissue. Pharmacology 49, 23-32.
23. McCaughran JA & Juno CJ (1988). Calcium channel blockade with verapamil. Effects on blood pressure, renal, and myocardial adrenergic, cholinergic, and calcium channel receptors in inbred Dahl hypertension-sensitive (S/JR) and hypertension-resistant (R/JR) rats. Am J Hypertens 1, 255S-262S.
24. Meissner M, Weissgerber P, Londono JEC, Molkentin JD, Nilius B, Flockerzi V & Freichel M (2009). Temporally regulated inactivation of the loxP-targeted CaVβ2 gene in the adult mouse heart. Naunyn Schmiedebergs Arch Pharmacol 379(Suppl. 1), 30-31.
25. Merlie JP & Smith MM (1986). Synthesis and assembly of acetylcholine receptor, a multisubunit membrane glycoprotein. J Membr Biol 91, 1-10.
26. 2+-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Cα. Circulation 103, 140-147.
27. 2+ channel in transgenic mice. Loss of isoproterenol-induced contraction. J Biol Chem 274, 21503-21506.
28. 2+ channel. Biochem Biophys Res Commun 344, 920-925.
29. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH & Grace AA (2002). Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A 99, 6210-6215.
30. Piacentino III V, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM & Houser SR (2003). Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92, 651-658.
31. Pitt GS, Dun W & Boyden PA (2006). Remodeled cardiac calcium channels. J Mol Cell Cardiol 41, 373-388.
32. II-deficient mice. Biophys J 78, 2878-2891.
33. Rosati B, Dong M, Cheng L, Liou SR, Yan Q, Park JY, Shiang E, Sanguinetti M, Wang HS & McKinnon D (2008). Evolution of ventricular myocyte electrophysiology. Physiol Genomics 35, 262-272.
34. 2+ currents in canine Purkinje fibres. J Physiol 579, 465-471.
35. Rosati B, Grau F, Kuehler A, Rodriguez S & McKinnon D (2004). Comparison of different probe-level analysis techniques for oligonucleotide microarrays. Biotechniques 36, 316-322.
36. Rosati B & McKinnon D (2004). Regulation of ion channel expression. Circ Res 94, 874-883.
37. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A 93, 2208-2212.
38. Sauro HM (2009). Network dynamics. Methods Mol Biol 541, 269.
39. Schroder E, Byse M & Satin J (2009). L-type calcium channel C terminus autoregulates transcription. Circ Res 104, 1373-1381.
40. Ca, L in mouse ventricle. Am J Physiol Heart Circ Physiol 292, H1906-H1916.
41. Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, Schwinger RH, Weil J & Herzig S (1998). Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 98, 969-976.
42. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM & Molkentin JD (2001). Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89, 20-25.
43. Tomaselli GF & Marban E (1999). Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42, 270-283.
44. Tzingounis AV & Nicoll RA (2008). Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. Proc Natl Acad Sci U S A 105, 19974-19979.
45. Wagner A (2007). Robustness and Evolvability in Living Systems. Princeton University Press, Princeton
46. Wang D, Papp AC, Binkley PF, Johnson JA & Sadee W (2006). Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel α subunit 1C in human heart tissues. Pharmacogenet Genomics 16, 735-745.
47. 1CTG mouse. PLoS One 4, e4133.
48. Wang Z, Tristani-Firouzi M, Xu Q, Lin M, Keating MT & Sanguinetti MC (1999). Functional effects of mutations in KvLQT1 that cause long QT syndrome. J Cardiovasc Electrophysiol 10, 817-826.
49. V1.2 disrupts remote spatial memories in mice. Learn Mem 15, 1-5.
50. Xu M, Welling A, Paparisto S, Hofmann F & Klugbauer N (2003). Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice. J Biol Chem 278, 40837-40841.
51. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T & Catterall WA (2006). Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9, 1142-1149.